Vanda Pharmaceuticals Inc. recently confirmed receipt of an updated unsolicited purchase offer from Future Pak, LLC. Composed of a cash payout ranging from $7.25 to $7.75 per share plus certain Contingent Value Rights, the revised proposal follows Vanda's previous examination and dismissal of Future Pak's original acquisition offer at the same price range. Moving forward, Vanda has committed to a thorough review and evaluation of the revised unsolicited proposal before deciding on action steps that best serve the interests of the company and its shareholders.